HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Carmela De Marco Selected Research
Carmela De Marco Research Topics
Disease
12
Neoplasms (Cancer)
10/2022 - 06/2007
6
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2012
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2017 - 01/2012
4
Carcinoma (Carcinomatosis)
05/2016 - 06/2007
4
Thyroid Neoplasms (Thyroid Cancer)
06/2010 - 03/2005
3
Melanoma (Melanoma, Malignant)
02/2023 - 12/2011
2
Hyperplasia
01/2019 - 01/2016
1
COVID-19
10/2022
1
Infections
01/2022
1
Inflammation (Inflammations)
01/2022
1
Parkinson Disease (Parkinson's Disease)
01/2022
1
Neuroinflammatory Diseases
01/2022
1
Ovarian Neoplasms (Ovarian Cancer)
03/2021
1
Ovarian Epithelial Carcinoma
05/2016
1
Tics (Tic)
12/2015
1
Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
03/2012
1
Adenocarcinoma
03/2008
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2008
1
Adenoma (Adenomas)
06/2007
1
Breast Neoplasms (Breast Cancer)
08/2004
Drug/Important Bio-Agent (IBA)
3
Cyclin-Dependent Kinases (cdk Proteins)
IBA
03/2012 - 08/2004
3
Messenger RNA (mRNA)
IBA
03/2012 - 06/2010
2
MicroRNAs (MicroRNA)
IBA
01/2022 - 03/2017
2
Small Interfering RNA (siRNA)
IBA
03/2021 - 12/2015
2
Protein Kinases (Protein Kinase)
IBA
01/2017 - 03/2008
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2017 - 03/2012
2
Cyclin-Dependent Kinase Inhibitor p27
IBA
03/2012 - 06/2007
2
Phosphotransferases (Kinase)
IBA
01/2012 - 11/2007
2
RNA (Ribonucleic Acid)
IBA
01/2012 - 12/2011
2
Proteins (Proteins, Gene)
FDA Link
12/2011 - 11/2007
1
Immune Checkpoint Inhibitors
IBA
02/2023
1
Monoclonal Antibodies
IBA
10/2022
1
Antiviral Agents (Antivirals)
IBA
10/2022
1
Cyclin D1
IBA
05/2022
1
Volatile Fatty Acids
IBA
01/2022
1
Suspensions
IBA
01/2022
1
Cytokines
IBA
01/2022
1
Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
IBA
01/2022
1
Proteasome Inhibitors
IBA
01/2019
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2019
1
3- (4- methylphenylsulfonyl)- 2- propenenitrile
IBA
01/2019
1
Bortezomib (Velcade)
FDA Link
01/2019
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2017
1
Platinum
IBA
05/2016
1
Aurora Kinase A
IBA
05/2016
1
Hyaluronic Acid (Hyaluronan)
IBA
05/2016
1
perfluoropolyether
IBA
05/2016
1
Urethane (Ethyl Carbamate)
IBA
01/2016
1
Carcinogens
IBA
01/2016
1
NF-kappa B (NF-kB)
IBA
12/2015
1
Interleukin-6 (Interleukin 6)
IBA
12/2015
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
12/2015
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2013
1
Protein Tyrosine Phosphatases
IBA
03/2012
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
03/2012
1
Phosphotyrosine
IBA
03/2012
1
Tyrosine (L-Tyrosine)
FDA Link
03/2012
1
6-pyruvoyltetrahydropterin synthase (PTPS)
IBA
03/2012
1
ErbB Receptors (EGF Receptor)
IBA
03/2012
1
Transcription Factors (Transcription Factor)
IBA
01/2012
1
Apoferritins
IBA
12/2011
1
Ferritins (Ferritin)
IBA
12/2011
1
Proteome
IBA
12/2011
1
Iron
IBA
12/2011
1
Nucleotides
IBA
03/2008
1
N 30
IBA
11/2007
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2007
1
Antisense Oligonucleotides
IBA
11/2007
1
Racivir
IBA
06/2007
1
S-Phase Kinase-Associated Proteins (Skp1 Protein)
IBA
06/2007
1
Phospho-Specific Antibodies
IBA
03/2005
1
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
08/2004
Therapy/Procedure
4
Therapeutics
02/2023 - 05/2016
2
Drug Therapy (Chemotherapy)
01/2021 - 05/2016
1
Secondary Prevention
10/2022
1
Home Nursing (Nursing, Home)
01/2022